Azathioprine Induced Pancreatitis in a Patient with Co-Existing Autoimmune Pancreatitis and Hepatitis

  • Preethi G K Venkatesh Digestive Disease Institute, Cleveland Clinic Foundation. Cleveland, OH, USA
  • Udayakumar Navaneethan Digestive Disease Institute, Cleveland Clinic Foundation. Cleveland, OH, USA
Keywords: Autoimmune Diseases, Azathioprine, Endoscopy, Pancreatic Pseudocyst, Pancreatitis

Abstract

Context Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug. Azathioprine is used in treating relapses in patients with autoimmune pancreatitis and maintenance of remission in autoimmune hepatitis. Acute pancreatitis complicated by symptomatic pseudocysts requiring drainage is not usually associated with drug induced pancreatitis. The risk of azathioprine use in patients with underlying disease of pancreas including autoimmune pancreatitis is unclear. Case report We report here a case of an African American patient with co-existing autoimmune pancreatitis and autoimmune hepatitis who developed azathioprine induced acute pancreatitis complicated by a large symptomatic pseudocyst compressing the duodenum requiring a cystoduodenostomy. Conclusions Future studies to investigate the risk of azathioprine induced pancreatitis in the presence of underlying disease of the pancreas including autoimmune pancreatitis are required to further understand the safety of azathioprine in this sub group of patients.

Image: Pseudocyst in the head of the pancreas compressing the common bile duct and duodenum.

Downloads

Download data is not yet available.

References

Herrlinger KR, Stange EF. The pancreas and inflammatory bowel diseases. Int J Pancreatol 2000; 27:171-9. [PMID 10952399]

Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicentre study. The Rapamune US Study Group. Lancet 2000; 356:194-202. [PMID 10963197]

Frick TW, Fryd DS, Sutherland DE, Goodale RL, Simmons RL, Najarian JS. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987; 154:487-9. [PMID 2445214]

Frick TW, Fryd DS, Goodale RL, Simmons RL, Sutherland DE, Najarian JS. Lack of association between azathioprine and acute pancreatitis in renal transplantation patients. Lancet 1991; 337:251-2. [PMID 1670892]

Haber CJ, Meltzer SJ, Present DH, Korelitz BI. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment if inflammatory bowel disease. Gastroenterology 1986; 91:982-6. [PMID 2427386]

Mallory A, Kern F Jr. Drug induced pancreatitis: A critical review. Gastroenterology 1980; 78:813-20. [PMID 6986321]

Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine induced pancreatitis. Aliment Pharmacol Ther 2008; 28:623-8. [PMID 18513380]

Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2000:CD000545. [PMID 10796557]

Floyd A, Pedersen L, Nielsen GL, Thorlacius-Ussing O, Sorensen HT. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Am J Gastroenterol 2003; 98:1305-8. [PMID 12818274]

Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38:982-4. [PMID 14614606]

Park DH, Kim MH Dr, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009; 58:1680-9. [PMID 19240063]

Deheragoda MG, Church NI, Rodriguez-Justo M, Munson P, Sandanayake N, Seward EW, et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007; 5:1229-34. [PMID 17702660]

Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4:1010-6. [PMID 16843735]

Hochwald SN, Hemming AW, Draganov P, Vogel SB, Dixon LR, Grobmyer SR. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution. Ann Surg Oncol 2008; 15:1147-54. [PMID 18219538]

Chen RY, Adams DB. IgG4 levels in non-Japanese patients with autoimmune sclerosing pancreatitis. N Engl J Med 2002; 346:1919. [PMID 12063386]

Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-8. [PMID 11236777]

Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333:958-63. [PMID 7666914]

Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102:2417-25. [PMID 17894845]

Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7:1089-96. [PMID 19345283]

Haber CJ, Meltzer SJ, Present DH, Korelitz BI. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment if inflammatory bowel disease. Gastroenterology 1986; 91:982-6. [PMID 2427386]

Mallory A, Kern F Jr. Drug induced pancreatitis: A critical review. Gastroenterology 1980; 78:813-20. [PMID 6986321]

Sturdevant RA, Singleton JW, Deren JL, Law DH, McCleery JL. Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology 1979; 77:883-6. [PMID 38178]

Villarreal HA, Wells LD, Neusschwander-Tetri BA. Azathioprine induced acute pancreatitis in mice. Gastroenterology 1995; 108(Suppl.):A398. ]

Foitzik T, Forgacs B, Ryschich E, Hotz H, Gebhardt MM, Buhr HJ, Klar E. Effect of different immunosuppressive agents on acute pancreatitis. A comparative study in an improved animal model. Transplantation 1998; 65:1030-6. [PMID 9583861]

Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005; 5:234-8. [PMID 15855821]

Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001; 36:293-302. [PMID 11388391]

Kubota K, Iida H, Fujisawa T, Yoneda M, Inamori M, Abe Y, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66:1142-51. [PMID 18061714]

Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Sawabu N. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas 2005; 30:31-9. [PMID 15632697]

Matsushita M, Yamashina M, Ikeura T, Shimatani M, Uchida K, Takaoka M, Okazaki K. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol 2007; 102:220-1. [PMID 17278279]

Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol 2007; 42(Suppl 18):59-62. [PMID 17520225]

Muraki T, Hamano H, Ochi Y, Arakura N, Takayama M, Komatsu K, et al. Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J Gastroenterol 2005; 40:761-6. [PMID 16082595]

Nishimura T, Masaoka T, Suzuki H, Aiura K, Nagata H, Ishii H. Autoimmune pancreatitis with pseudocysts. J Gastroenterol 2004; 39:1005-10. [PMID 15549456]

Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 35:7-13. [PMID 11786954]

Poupon R, Poupon RE. Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000; 14:615-28. [PMID 10976018]

Weersma RK, Peters FT, Oostenbrug LE, van den Berg AP, van Haastert M, Ploeg RJ, et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 2004; 15:834:50. [PMID 15479355]

Bajaj JS, Saeian K, Varma RR, Franco J, Knox JF, Podoll J, et al. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. Am J Gastroenterol 2005; 100:1121-5. [PMID 15842588]

Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46(Suppl 1):48-55. [PMID 20862498]

Pseudocyst in the head of the pancreas compressing the common bile duct and duodenum
Published
2011-05-06
How to Cite
VenkateshP., & NavaneethanU. (2011). Azathioprine Induced Pancreatitis in a Patient with Co-Existing Autoimmune Pancreatitis and Hepatitis. JOP. Journal of the Pancreas, 12(3), 250-254. https://doi.org/10.6092/1590-8577/3291
Section
CASE REPORT